HealthDay News — Distribution of prescribed opioid analgesics is lower in majority non-White versus majority White communities across all levels of socioeconomic deprivation, according to a study ...

Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of therapy.

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

The oral drug, branded Journavx, works by blocking pain signals at their source, unlike opioids — which trigger the brain's reward centers as they travel through the blood and then attach to ...

It is expensive, with a list price of $15.50 per pill. But unlike opioid pain medicines, it cannot become addictive. That is because the drug, suzetrigine, made by Vertex Pharmaceuticals and to be ...

Journavx (suzetrigine), a non-opioid pill for moderate-to-severe acute pain, has just received FDA approval. It’s the first drug in a new family of medicines that block pain signals before they ...

An estimated 2.5 million American adults have an addiction to opioids, which were responsible for more than 107,000 fatal overdoses in 2023. Next in the study, published in the journal Drug ...

The Kroger Co. has agreed to pay Kentucky $110 million to settle a lawsuit filed last year alleging it pumped millions of doses of opioids into the state over the course of more than a decade.

COVINGTON, Ky. — Kroger will pay Kentucky $110 million in settlement funds that will ultimately go to combat the opioid crisis Kentucky Attorney General Russell Coleman says the business helped ...